Mélanie Desbois
About Mélanie Desbois
Mélanie Desbois is a Biomarker Scientist currently working at IGM Biosciences, Inc. She has extensive experience in cancer immunology and biomarker research, having previously held positions at Genentech and Cytune Pharma SAS.
Current Role at IGM Biosciences
Mélanie Desbois has been working as a Biomarker Scientist at IGM Biosciences, Inc. since 2020. In this role, she specializes in investigating mechanisms of action and resistances to inform therapeutic strategies and biomarkers. Her expertise includes handling both mouse and human tissues for research purposes, contributing to the development of innovative biomarker strategies.
Previous Experience at Genentech
Prior to her current position, Mélanie Desbois worked at Genentech as a Postdoctoral Scientist from 2015 to 2019. During her four years in South San Francisco, she focused on advancing research in the field of cancer immunology, building on her extensive background in the subject.
Research Background at Gustave Roussy
Mélanie Desbois has a significant research background at Gustave Roussy, where she held multiple positions. She served as a PhD student in Cancer Immunology from 2010 to 2014, and as a Postdoctoral Scientist from 2014 to 2015. Additionally, she completed Master 2 and Master 1 internships in Cancer Immunology and Cell Therapy, respectively, from 2009 to 2010 and in 2009.
Education and Academic Qualifications
Mélanie Desbois holds a Doctorate in Philosophy with a focus on Immunology from Paris - Sud University (Paris XI), obtained between 2010 and 2014. She also earned a Master of Science in Immunology from Sorbonne Université from 2008 to 2010, and a Bachelor of Science from the same institution from 2006 to 2008. Her academic journey included a brief study at Institut Pasteur in 2009.
Technical Expertise in Immunology
Mélanie Desbois possesses hands-on experience with advanced immunology techniques, including 15-color flow cytometry, ELISA, and Luminex assays. She has a strong background in cancer immunology, focusing on the biology of NK and T cells, as well as stromal cells. Her expertise extends to molecular biology techniques, including RNAseq and single-cell RNAseq, encompassing RNA extraction and data interpretation.